Holen Sie sich die Stockscreener-App
5.57
5.11%
-0.30
Handel nachbörslich:
5.58
0.010
+0.18%
Schlusskurs vom Vortag:
$5.87
Offen:
$5.86
24-Stunden-Volumen:
1.45M
Relative Volume:
1.08
Marktkapitalisierung:
$559.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-242.30M
KGV:
-2.246
EPS:
-2.48
Netto-Cashflow:
$-192.10M
1W Leistung:
+13.44%
1M Leistung:
+16.77%
6M Leistung:
-44.24%
1J Leistung:
-26.03%
1-Tages-Spanne:
$5.525
$5.875
1-Wochen-Bereich:
$4.82
$5.89
52-Wochen-Spanne:
$3.72
$12.61
Cogent Biosciences Inc Stock (COGT) Company Profile
Firmenname
Cogent Biosciences Inc
Sektor
Branche
Telefon
617-945-5576
Adresse
275 WYMAN STREET, WALTHAM
Vergleichen Sie COGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
5.57 | 559.04M | 0 | -242.30M | -192.10M | -2.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.50 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-11 | Herabstufung | Needham | Buy → Hold |
| 2024-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | Eingeleitet | Citigroup | Buy |
| 2023-12-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-12-08 | Eingeleitet | JP Morgan | Overweight |
| 2023-04-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-06-28 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-06-09 | Fortgesetzt | Jefferies | Buy |
| 2020-12-23 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Cogent Biosciences Inc Aktie (COGT) Neueste Nachrichten
Is Cogent Biosciences, Inc. (COGT) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Yahoo Finance
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Invesco Ltd. - Defense World
Barclays PLC Has $1.51 Million Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Sees Unusually High Options Volume (NASDAQ:COGT) - Defense World
Cogent Biosciences Inc [COGT] Records 200-Day SMA of $8.76 - knoxdaily.com
JPMorgan Chase & Co. Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Get in on Cogent Biosciences Inc’s (COGT) buy-in window today! - Sete News
Legal & General Group Plc Has $542,000 Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Inc (COGT) Stock: The Story of a 52-Week Stock Range - investchronicle.com
Financial Metrics Check: Cogent Biosciences Inc (COGT)’s Ratios for Trailing Twelve Months - DWinneX
Results from Cogent Biosciences Inc (COGT) show potential - uspostnews.com
Understanding the Risks of Investing in Cogent Biosciences Inc (COGT) - knoxdaily.com
Let’s Jump Into The Cogent Biosciences Inc (NASDAQ: COGT) Stock Forecast - Marketing Sentinel
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.43 Consensus Target Price from Brokerages - Defense World
Cogent Appoints New Senior Executives to Lead Market Access and Corporate Strategy | COGT Stock News - GuruFocus
Cogent Biosciences Presents Four Posters at the American Associa - GuruFocus
Cogent Biosciences (COGT) Unveils Promising Preclinical Data on Cancer Inhibitors | COGT Stock News - GuruFocus
Cogent Biosciences, Inc. Unveils Preclinical Data from Four Pipeline Programs at AACR 2025 Annual Meeting - Nasdaq
Cogent Biosciences Presents Four Posters at the American - GlobeNewswire
Breakthrough: Cogent's Cancer Drug Achieves 90% Tumor Inhibition, Plus 3 More Pipeline Advances - Stock Titan
Cogent Biosciences Inc [COGT] Records 50-Day SMA of $6.47 - knoxdaily.com
Perhaps timely catching Cogent Biosciences Inc (COGT) would be a good idea - Sete News
Metric Analysis: Cogent Biosciences Inc (COGT)’s Key Ratios in the Limelight - DWinneX
Cogent Biosciences Inc (COGT) did well last session? - uspostnews.com
Cogent Biosciences Inc (COGT) Becoming More Attractive for Investors - knoxdaily.com
(COGT) Technical Data - news.stocktradersdaily.com
Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts - Insider Monkey
Geode Capital Management LLC Boosts Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Is Cogent Biosciences Inc. (NASDAQ:COGT) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight - GlobeNewswire Inc.
Vanguard Group Inc. Purchases 418,975 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Wellington Management Group LLP Trims Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
KLP Kapitalforvaltning AS Takes $88,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Corebridge Financial Inc. - Defense World
Cogent: Several 2025 Readouts On Deck With Bezuclastinib Advancement - Seeking Alpha
Cogent Biosciences stock hits 52-week low at $4.24 By Investing.com - Investing.com South Africa
Cogent Biosciences stock hits 52-week low at $4.24 - Investing.com
Trend Tracker for (COGT) - news.stocktradersdaily.com
Teacher Retirement System of Texas Grows Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.43 Consensus PT from Brokerages - Defense World
When Would Be The Best Time To Buy Cogent Biosciences Inc (NASDAQ: COGT) Stock? - stocksregister.com
21,653 Shares in Cogent Biosciences, Inc. (NASDAQ:COGT) Bought by Quantbot Technologies LP - Defense World
21,653 Shares in Cogent Biosciences, Inc. (NASDAQ:COGT) Purchased by Quantbot Technologies LP - The AM Reporter
Swiss National Bank Sells 3,000 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
We're Keeping An Eye On Cogent Biosciences' (NASDAQ:COGT) Cash Burn Rate - Yahoo
Proficio Capital Partners LLC Buys New Shares in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Announces Multiple Poster Presentations - GlobeNewswire
Cogent Biosciences Announces Multiple Poster Presentations At 2025 American Association For Cancer Research (AACR) Annual Meeting - MarketScreener
Cogent's Cancer Breakthrough: 4 Precision Therapies Target KRAS, HER2, and Drug Resistance - StockTitan
Charles Schwab Investment Management Inc. Boosts Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Bank of New York Mellon Corp Has $2.02 Million Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
3.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):